Alternatives to New Dawn Bio

Developing high-performance, compostable foams from bacterial cellulose to replace fossil-based plastics.

UK biotechnology company developing sustainable natural rubber from engineered dandelions.

Developing and industrializing cellulose-based superabsorbent materials as a fossil-free and biodegradable alternative.

A University of Cambridge spin-out tackling unmet drug screening needs by combining materials engineering and cell biology.

Turning CO2 into cellulose for textiles using an innovative, carbon-negative enzymatic process.

Pioneering Liquid State Intelligence for physical-world AI.

Developing biobased alternatives to conventional carbon-intensive construction binders.

Developing circular biomass technology.

Empowering Venture Scientists to solve neglected health and planetary challenges through an entrepreneurship-focused doctoral training program.

Developing a sustainable plastic alternative called Vivomer.

Notpla develops and produces sustainable, plastic-free packaging solutions from seaweed and plants, offering biodegradable and compostable alternatives for various applications.

Developing next-generation nanozyme catalysts to enable a more sustainable and efficient chemical production industry.

Developing a new generation of molecular diagnostics for at-home use, combining laboratory accuracy with rapid test simplicity.

Develops and commercializes biological solutions for pest control in plant, home, and public health sectors.

Epoch Biodesign uses enzymes to break down plastic waste into monomers for new plastic production.

Develops and distributes bioreactor technology for stem cell cultivation.

North American subsidiary of CTIBIOTECH, a leader in 3D bioprinting of human tissue.

A leading incubator and venture builder in deep tech and life science.

Revolutionizing battery recycling for a circular future in Europe.

Industrial biotechnology company developing optogenetic control for industrial-scale precision fermentation.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

Sustainable fats from carbon, revolutionizing food ingredients and personal care.

Building industrial hardware from the atoms up using AI.

Developing a recyclable and biodegradable bio-based foam material to replace harmful plastic foams.

Developing proprietary nano-ink technology for inkjet printing of printed circuit boards (PCBs).

Graphene technology for faster AI data transfer

Making faster, cheaper, and better composites.

Charter Next Generation is a company focused on developing advanced materials for flexible electronics and displays.

Develops eco-positive, scalable solutions for textile fiber and fabric dyeing.

Magnus Metal is developing advanced metal alloys for high-performance applications, focusing on sustainability and efficiency.

AI safety and research company building reliable, interpretable, and steerable AI systems.

Building foundational AI superintelligence to accelerate scientific knowledge discovery and breakthroughs across complex domains.

Danish biofuel startup developing a patented process to convert lignin-based residues into climate-neutral marine fuels.

Global biopharmaceutical company pioneering mRNA-based immunotherapies and vaccines for cancer and infectious diseases.

Next-generation metals processing infrastructure for critical and precious metals recovery.

Turning low-grade plastic waste into building materials and home products.

Biotechnology company developing and commercializing cell therapies for cancer treatment.

Revolutionary refrigerant-free cooling and heating technology.

Developing cellulose-based alternatives to titanium dioxide for cosmetics, food, and coatings.

Biotechnology company developing transformative gene-based medicines using CRISPR/Cas9 gene editing technology.

Europe's only producer of Gallium Oxide epiwafers for next-generation power semiconductor devices.

Biotechnology company leveraging ultracompact CRISPR systems for gene editing therapies and diagnostics.

Clinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.

Developing novel therapeutics to restore gut lymphatic function.

Clinical-stage biotechnology company developing autologous neuron replacement medicines for neurodegenerative disorders.

Epicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).

Spatial multiomics company developing technologies for single-cell gene expression profiling in intact tissues.

Global supplier of life science research tools, including antibodies, reagents, and assays.

A clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.

Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.

Clinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.

A vertically-integrated procurement platform for the life sciences industry.